Navigation Links
Genetic Eye Disorder Can Have Other Implications

Rare eye disorder from genetic sources can also be responsible for other effects in the brain and fetal cardiovascular development.

Researchers at Children’s Hospital Boston, who specialize in studying the genetics // of rare eye-movement disorders, have found a rare genetic syndrome whose implications go far beyond the eye, raising intriguing questions about human cardiovascular and brain development.

The syndrome involves a mutation to HOXA1, a gene that has been extensively studied in mice, but about which little is known in humans. HOXA1 belongs to a large family of HOX genes that govern very early embryonic development and the making of the body plan. HOXA1 is the first HOX gene turned on in mice, and presumably in the human body, and is involved in patterning of the growth of the head, face, and brainstem.

Mice that lack both copies of HOXA1 universally die. Until this study, no human HOXA1 mutation had ever been identified, and it was assumed that complete loss of HOXA1 function would be lethal. But the Children’s investigators, have found living people with two mutated copies of HOXA1 -- from three different parts of the world.

Researchers had been studying genetic disorders that interfere with peoples’ ability to move their eyes horizontally (left or right). Collaborators in Saudi Arabia alerted them to patients they’d been seeing who had not only restricted horizontal eye movement, but also deafness and motor impairments. The Saudi clinicians began to carefully reexamine their patients, while US researchers looked at the patients’ DNA to try to identify a causative gene.

All 9 patients with the syndrome (dubbed Bosley-Salih-Alorainy syndrome, or BSAS, after the Saudi discoverers) had horizontal gaze abnormalities. Eight were profoundly deaf, 3 had external ear defects, 7 had delayed motor development, and 2 met criteria for autism spectrum disorder with cognitive and behavioral impairment. In addition,
'"/>




Page: 1 2

Related medicine news :

1. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
2. Genetic influence in menopause
3. Genetics and cholesterol levels
4. Genetics helps in attacking cancer
5. Genetic disorder related with sleep patterns
6. Genetic innovation
7. Genetic tests for cancer
8. Genetic indicates memory
9. Genetic mutation to the fountain of youth discovered
10. Genetic differences found between Male and Female brains
11. Alcoholism Influenced By Both Genetics & Family Environment
Post Your Comments:
(Date:7/25/2008)... Management to discuss second quarter financial re.../ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today ...riday, August 8 at 8:30 a.m. (ET) to discuss its s...ll report its second quarter 2008 financial,result...same day., To access the conference call by telep...
(Date:7/25/2008)...f certain cleaning products reduces lung function,... , FRIDAY, July 25 (HealthDay News) -- A clean, ...ealth, depending on what type of cleaning and air ...suggests that exposure to cleaning products or air...c compound (VOC) called 1,4 dicholorobenzene (1,4 ...
(Date:7/25/2008)...ALLAS, July 25 /PRNewswire/ -- BeaconEquity.com an... making news today., Investors can view all of th...//BeaconEquity.com/m , Today,s Trade Alerts inclu...ddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK ), N... ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abax...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Beg...all/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI )...unced today that its subsidiary has commenced comm...Capsules USP product in the 40mg,strength from its...tion,with the launch, Watson has 180 days of marke...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2
... has been identified by researchers that help thos...is gene seems to confer a preserving effect upon t...as presented by scientists from the Albert Einstei...sity. December 26, 2006 issue of Neurology publish...
...an holds the hand of a little boy, looking at a ro... area, which was in wreck two years ago, washed aw...m village is exuding life now. Along the innocent-... of Chennai, India, new casurina saplings are knee...
... care is set to boom following expectations of the...ars. // The four per cent increase equates to abou...bated premium of $1,750, will begin in April. The ...include a wide range of medical services including...
...int flavored sweetener, produced naturally by plan...used as an ingredient in chewing gum, toothpaste, ...ist at Agricultural Research Service (ARS) and col...y engineered bacteria, a modified form of Escheric...
Other Medicine News:Health News:You may Live Long and Think Clear With a Variant Gene 2Health News:Tsunami-Hit Coastal Regions Needs More Relief 2Health News:Xylitol To Be Produced By Genetically Engineered E. Coli 2
(Date:7/22/2008)... 22 /- Following a,thorough...f Progen,Pharmaceuticals Limited (ASX: PGL; Nasdaq...he PI-88 phase 3 study in liver cancer. Progen con...ting portfolio of compounds and,the company will a...pportunities through Merger & Acquisition activity...
(Date:7/22/2008)...peutics Development Initiative bring MJFF,s,curren...ine January 20,2009, NEW YORK, July 22 /PRNewswi...delivery of transformative treatments and a cure f...ion for Parkinson,s Research has awarded,$2.7 mill...s. The awards,were granted under MJFF,s Therapeuti...
(Date:7/22/2008)... Confirms Tyrima Exhibits Excellent Drug-Like ...lts Support Initiation of Phase II Clinical Trials...wire/ -- CeNeRx BioPharma,Inc., a clinical stage ...treatments for diseases of the central nervous sys...didate Tyrima(TM) into Phase II trials for the,tre...
(Date:7/22/2008)...f., July 22 /- Hyperion,Therapeutics,...t enrollment,in its Phase 1/2 clinical trial to ev...ging effects of HPN-100 (formally called GT4P) ver...s with urea cycle disorders,(UCD). The company pla...ter,of this year., (Logo: http://www.newscom.com...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Easy Does It Eases Holiday Stress 8766 1Easy Does It Eases Holiday Stress 8766 2Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 1Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 2Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 3Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 1Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 2Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 3Gold nanoparticle probes may allow earlier cancer detection 8756 1Gold nanoparticle probes may allow earlier cancer detection 8756 2Gold nanoparticle probes may allow earlier cancer detection 8756 3
Rotating 360 degrees, 3 mm x 7 mm bite.
Right side cutting.
Backward cutting, 3 mm x 7 mm bite, length of shaft 100 mm, overall length 7 inches.
20 mm. Plastic, methylmethacrylate. Supplied sterile.
Medicine Products: